Deep-dive market analysis and go-to-market recommendation for Vancouver Laser & Skin Care Centre's potential acquisition of the DEKA Onda Pro
Onda Pro arrived in North America only in late April 2026, and only two Lower Mainland clinics currently offer it. The device's real strategic value to Vancouver Laser & Skin Care Centre (VLSCC) is not as another fat-reduction machine — it is the clinic's first cellulite treatment, its first body-focused "tighten while you slim" platform, and the natural answer to the post-GLP-1 ("Ozempic body") patient that the existing menu serves poorly. Marketed head-on against CoolSculpting, Onda would cannibalize VLSCC's largest body franchise; marketed as a refinement-and-tightening layer, it extends it.
Bottom line: a conditional go. The window to claim "Vancouver's medical flagship for Onda Pro" is open but closing — BN Skin & Laser already claims flagship status and has set a $1,400/body-area price anchor. VLSCC's physician-led credibility, 1,000+ review base, Broadway-corridor location, and existing body-contouring patient file are stronger launch assets than either incumbent has. Before purchase, verify the Health Canada device licence and get firm capex + protocol economics from Cartessa (details in §2 and §8).
Onda is a family of devices from DEKA M.E.L.A. srl (Calenzano, Italy) using patented "Coolwaves" — 2.45 GHz microwaves at up to 200 W with contact skin cooling. The energy selectively heats subcutaneous fat, triggering adipocyte lipolysis while remodelling collagen — which is why one platform claims three indications: localized fat reduction, skin tightening, and cellulite. The line evolved from the original Onda (2018) through Onda Plus to today's Onda Pro, which adds a third "Pocket" handpiece (3 mm focal depth) enabling face, jawline and submental treatment alongside the Deep (12 mm, large-area fat) and Shallow (cellulite/tightening) handpieces.
Key commercial facts:
Neither Cartessa's launch release nor DEKA's site cites a Health Canada medical device licence number for Onda Pro. Nothing suggests a problem — but confirm the active MDALL listing (search "DEKA M.E.L.A." / "ONDA") and the licensed indications before signing, since licensed indications constrain what marketing claims are legal in Canada.
Note on the links reviewed: thecoolwaves.com is DEKA's official global product-marketing site, not a clinic — it carries no pricing or promotions. The Face Lab article describes that Toronto clinic's June 2026 flagship launch; its playbook is analyzed in §7 and §10.
Exhaustive searching (including Korean-language queries, since the device has strong Korean-market presence) surfaced only two confirmed providers in the Lower Mainland as of August 2026. No providers were found in Vancouver proper, Burnaby, Surrey, New Westminster, North Vancouver, Langley, Delta, White Rock, Abbotsford or Maple Ridge.
| Clinic | Locations | Positioning | Notes |
|---|---|---|---|
| BN Skin & Laser Clinic bnskinlaser.com |
West Vancouver (1760 Marine Dr) + Richmond | Self-styled "Official Onda PRO Flagship Center in Vancouver, Canada." Face-led ("Onda Lifting") with body areas secondary. Korean/Chinese-market oriented (Seoul clinic partnership, KakaoTalk/WeChat, WeChat Pay). "Best of Vancouver 2023." | Prices by kJ dose: $700 chin → $1,400 body area. Runs frequent promo events and a $1,600/yr membership. |
| Derma 9 Skin Rejuvenation Clinic derma9.ca |
Coquitlam (901 Lougheed Hwy) | Self-styled "Canada's First Luminary Clinic & Official Launch Partner" for Onda Pro. Face + body menu. | Undercuts BN: $580 face session, $980 full face / body, 3+1 face package $2,940. |
Two observations matter strategically. First, both incumbents' "official flagship / launch partner" claims overlap and are self-reported — Cartessa has not publicly named partners, so the "medical flagship" narrative in Vancouver proper is still unclaimed. Second, both incumbents lead with the face-lifting application and Korean-beauty positioning; nobody in the market owns the body/cellulite/post-weight-loss story, which is where the demand data points (§6). The closest analogue to what VLSCC could be is The Face Lab in Toronto, which launched in June 2026 as "Toronto's flagship clinic" targeting exactly that body-contouring narrative.
Caveat: clinics that market only on Instagram/WeChat/KakaoTalk may not surface in web search; a quick Instagram hashtag check (#온다리프팅 #ondapro) before launch is cheap insurance.
Local Onda pricing follows the Korean convention of pricing by energy dose (kJ) rather than by area or cycle. Toronto's Face Lab publishes no prices at all — consultation-gated pricing is part of its premium positioning.
Reading the range: a full recommended body course (4 sessions) at BN's rate is ~$5,600 per area — comparable to a multi-cycle CoolSculpting plan but with tightening and cellulite benefits included. Toronto benchmark pricing is hidden; US clinics likewise mostly gate pricing behind consultation. That means the public price anchor for Onda in Canada is being set right now by two suburban BC clinics — a pricing-power opportunity for a credible medical flagship (see §10).
The most important finding is how little organic North American review volume exists: no RealSelf treatment page or "Worth It" score, essentially no Reddit threads, and no device-specific mentions yet in the Google reviews of the Canadian clinics offering it. The device is simply too new here. Reviews from Asia, Europe and the UK (some promotional-adjacent — treat with care) are consistent on themes:
A 2024 international consensus paper (Bioengineering) reports median abdominal circumference reduction of −3.9 cm, trochanteric −2.8 cm, significant cellulite-scale improvement at 3 months, submental improvement over 6 sessions, and no reported adverse events — with satisfaction scores of 3.3–4.1/5. Supporting studies exist on histology, submental laxity, and postpartum laxity. Crucially for a heat-based mechanism, no cases of paradoxical adipose hyperplasia (PAH) have been reported for Onda — the complication that, at rates reported as high as ~1 in 138 in one series, drove the Linda Evangelista lawsuit and materially damaged CoolSculpting's consumer reputation.
The Onda literature is small, short-horizon, and partly manufacturer-adjacent; there is no published head-to-head trial vs. CoolSculpting or any competitor, and the widely-cited 1-year follow-up study (Salsi et al., Skin Research and Technology) has been retracted — never cite it. "No PAH reported" is honest; "zero PAH risk" is not defensible. Marketing copy should lean on comfort, downtime, the triple indication, and the consensus-paper numbers, with physician oversight as the trust layer.
Three currents define demand, and they point in different directions:
Locally: Metro Vancouver is dense with CoolSculpting, Emsculpt Neo and commodity RF (Venus et al.), but cellulite coverage is thin — among VLSCC's direct west-side rivals, only Arbutus Laser (VelaShape III) and Project Skin MD (EMTone) have a cellulite device, and only two clinics in the entire region have Onda, neither of them physician-flagship positioned in Vancouver proper. Consumer awareness of the Onda brand is near zero, which cuts both ways: no inbound search demand yet (marketing burden falls on the clinic), but also no established price/positioning expectations to fight.
| Player | Current promotional activity (Aug 2026) |
|---|---|
| BN Skin & Laser | "8.8 6th Anniversary" event (offers from $88); "Summer Body Project"; Thermage+Ultherapy combo promos; "First Trial Offer" discounted intro treatments; Glow Club membership $1,600/yr. (Whether Onda is included in the 8.8/Summer promos is unconfirmed.) |
| Derma 9 | July promo: free energy upgrade 60→80 kJ on full-face Onda; face package 3 sessions + 1 free ($2,940); an "August Special" exists but contents unconfirmed (page 404'd). |
| The Face Lab (Toronto benchmark) | No discounts at all. Launch mechanics instead: pre-launch priority waitlist (first access, priority consults, launch-event invites), consultation-gated pricing, payment plans. Premium scarcity playbook. |
Pattern: the incumbents discount (dose upgrades, +1 free sessions, event pricing); the premium entrant (Face Lab) refuses to discount and sells access instead.
Be the first physician-led clinic in Vancouver proper to offer Onda Pro — framed not as another fat gadget but as the clinic's dedicated answer to cellulite (a gap in VLSCC's own 40+ item menu and in most of the west-side competitive set) and to post-GLP-1 / post-pregnancy body renewal. First-mover framing is still available: no incumbent owns the body story, the medical story, or the English-language mainstream market.
| Factor | Assessment |
|---|---|
| Competitive whitespace | Strong. 2 suburban providers, both face-led, both K-beauty niche; zero in Vancouver proper; distributor HQ is downtown Vancouver (relationship leverage — negotiate launch support, possibly regional exclusivity or "training centre" status, as VLSCC did with Ultherapy). |
| Demand fit | Strong. Category rotating exactly toward Onda's tighten-while-you-slim profile; VLSCC's CoolSculpting franchise is exposed to the same −40% headwind and needs this hedge. |
| Economics | Favourable but unquantified. No consumables → high contribution margin per session and cheap "first session" promos; capex unconfirmed (~US$130–170k cited, low confidence). At BN's $1,400/area and 4-session protocols, payback plausibly < 18 months at modest utilization — model with real Cartessa numbers. |
| Risks | Real. Zero consumer brand awareness (VLSCC must create the demand it harvests); thin/partly-retracted evidence base constrains claims; results are gradual → expectation management is the #1 review-risk; Health Canada licence status to verify; internal channel conflict with the CoolSculpting investment. |
VLSCC's exposure, treatment by treatment, against Onda's three indications:
| VLSCC franchise | Overlap with Onda | Risk & management |
|---|---|---|
| CoolSculpting Elite ($800/cycle, 10 machines, Study Centre status) | High — same abdomen/flank/thigh/arm fat patient | Highest cannibalization risk and highest internal resistance (sunk capital, Allergan relationship). Manage by role separation: CoolSculpting = debulking discrete fat pockets on good-skin patients; Onda = fat with laxity, smaller refinements, cryo-averse patients, and post-GLP-1 deflation. These are different consult pathways, not competing offers. |
| Emsculpt Neo / CoolTone | Partial (Neo's RF fat component) | Low risk — muscle-building is distinct. Actively complementary: "Onda to refine and tighten, Emsculpt to build" is a published combination in the literature (waist −4.2 cm in the combo study) and a natural VLSCC bundle. |
| Thermage (body) (from $1,800) | Moderate on body tightening | VLSCC's Thermage volume appears face-skewed; position Onda as the body-tightening default (cheaper per session, more comfortable) and keep Thermage for face and single-session-preference patients. |
| Ultherapy / Sofwave / Sylfirm (face) | Low — unless VLSCC markets Onda's face "Pocket" handpiece | Deliberately do not lead with Onda-for-face. That's where VLSCC's tightening equity lives (#1 Ultherapy provider claim) — and it's also the incumbents' (BN/Derma 9) chosen ground. Hold face Onda in reserve. |
| Cellulite | None — pure white space | No cellulite offering exists on VLSCC's 40+ item menu today. Every cellulite patient Onda attracts is incremental revenue by definition. |
| Lipodissolve (from $575) | Low (small pockets, chin) | Keep as the budget/small-area option; Onda chin only if a patient is needle-averse. |
Net read: roughly two-thirds of Onda's indication set collides with existing VLSCC equity if marketed generically. The cannibalization problem is entirely a positioning problem — which the strategy below is built to solve.
Do not launch Onda as a fat-melting machine — that pits it against your own CoolSculpting floor and a saturated market. Launch it as a new category at the clinic: "Body Renewal — smooth, tighten and refine", anchored on the three things nothing else on your menu does: cellulite smoothing, skin tightening while reducing fat, and post-weight-loss (GLP-1/pregnancy) body restoration. Claim the title the incumbents haven't: "Vancouver's first physician-led Onda Pro clinic." Lean on the 30-years/physician-led/Study-Centre trust assets — that is the differentiator neither BN nor Derma 9 can copy, and it converts a novel device into a safe choice.
Codify one consult script across the clinic:
This does the strategic work: Onda never competes with CoolSculpting for the same body — it captures the patients CoolSculpting was losing (laxity, PAH-anxious, GLP-1) and adds a second ticket to the ones it keeps.
Flagged as unconfirmed in the research: Health Canada MDALL licence status; new Onda Pro capex; Derma 9's $980 body-price unit; contents of BN's 8.8/Summer promos and Derma 9's August special; whether BN/Derma 9 "official partner" claims are Cartessa-sanctioned; VLSCC Emsculpt Neo pricing (not published).
针对 Vancouver Laser & Skin Care Centre 拟购入 DEKA Onda Pro 的深度市场分析与上市营销建议
Onda Pro 于 2026 年 4 月底才登陆北美，目前低陆平原仅有两家诊所提供该疗程。对 Vancouver Laser & Skin Care Centre（VLSCC）而言，这台设备真正的战略价值并不在于"又一台减脂仪器"——它将是诊所的第一个橘皮组织（cellulite）疗程、第一个"边塑形边紧致"的身体平台，也是对现有菜单难以服务的"GLP-1 之后"（"Ozempic 身材"）患者的天然答案。若正面对标 CoolSculpting 营销，Onda 将蚕食 VLSCC 最大的身体项目；若定位为"精修与紧致"层级，它则是对现有业务的延伸。
结论：有条件推进。抢占"温哥华 Onda Pro 医学旗舰"称号的窗口仍在，但正在关闭——BN Skin & Laser 已自称旗舰，并设定了每个身体部位 $1,400 的价格锚点。VLSCC 的医生主导公信力、1,000+ 条评价基础、Broadway 医疗走廊的位置以及现成的身体塑形患者档案，都是两家现有诊所不具备的上市资产。购买前，请核实加拿大卫生部（Health Canada）设备许可证，并向 Cartessa 索取确定的设备成本与疗程经济模型（详见第2、8节）。
Onda 是意大利 DEKA M.E.L.A. srl（Calenzano）的设备系列，采用专利"Coolwaves"技术——2.45 GHz 微波、最高 200 W 输出，配合接触式皮肤冷却。能量选择性加热皮下脂肪，触发脂肪细胞分解，同时重塑胶原——因此一台平台宣称三大适应症：局部减脂、皮肤紧致、橘皮组织改善。产品线从初代 Onda（2018）经 Onda Plus 演进到如今的 Onda Pro，新增第三个"Pocket"手具（3 mm 聚焦深度），使面部、下颌线和颏下治疗成为可能，与 Deep（12 mm，大面积脂肪）和 Shallow（橘皮/紧致）手具并列。
关键商业事实：
Cartessa 的上市新闻稿与 DEKA 官网均未注明 Onda Pro 的加拿大卫生部医疗器械许可证编号。目前没有任何迹象表明存在问题——但签约前请在 MDALL 数据库确认有效登记（搜索 "DEKA M.E.L.A." / "ONDA"）及获批适应症，因为获批适应症决定了在加拿大哪些营销宣称是合法的。
关于所审阅链接的说明：thecoolwaves.com 是 DEKA 官方全球产品营销网站，并非诊所——无价格、无促销。The Face Lab 的文章描述的是该多伦多诊所 2026 年 6 月的旗舰上市；其打法在第7、10节中有分析。
经过详尽搜索（包括韩语检索，因该设备在韩国市场存在感很强），截至 2026 年 8 月，低陆平原仅确认两家提供者。温哥华市区、本拿比、素里、新西敏、北温、兰里、三角洲、白石、阿伯茨福德、枫树岭均未发现提供者。
| 诊所 | 位置 | 定位 | 备注 |
|---|---|---|---|
| BN Skin & Laser Clinic bnskinlaser.com |
西温哥华（1760 Marine Dr）+ 列治文 | 自称"加拿大温哥华官方 Onda PRO 旗舰中心"。以面部为主（"Onda 提升"），身体部位为辅。面向韩裔/华裔市场（与首尔诊所合作，KakaoTalk/微信，微信支付）。"Best of Vancouver 2023" 获奖者。 | 按 kJ 剂量计价：下巴 $700 → 身体部位 $1,400。频繁举办促销活动，并设有 $1,600/年会员。 |
| Derma 9 Skin Rejuvenation Clinic derma9.ca |
高贵林（901 Lougheed Hwy） | 自称 Onda Pro 的"加拿大首家 Luminary 诊所暨官方启动合作伙伴"。面部 + 身体菜单。 | 价格低于 BN：面部单次 $580，全脸/身体 $980，面部 3+1 套餐 $2,940。 |
两点战略观察。第一，两家现有诊所的"官方旗舰/启动合作伙伴"说法相互重叠且均为自我宣称——Cartessa 从未公开指定合作伙伴，因此温哥华市区的"医学旗舰"叙事仍无人认领。第二，两家都以面部提升应用和韩式美容定位为主打；市场上没有人占据身体/橘皮组织/减重后修复的叙事，而需求数据恰恰指向那里（第6节）。VLSCC 可以成为的角色，最接近的参照是多伦多的 The Face Lab——它于 2026 年 6 月以"多伦多旗舰诊所"身份上市，瞄准的正是身体塑形叙事。
注意：只在 Instagram/微信/KakaoTalk 上营销的诊所可能不会出现在网页搜索中；上市前快速检查一下 Instagram 标签（#온다리프팅 #ondapro）是低成本的保险。
本地 Onda 定价沿用韩国惯例——按能量剂量（kJ）而非按部位或周期计价。多伦多 Face Lab 完全不公开价格——咨询制定价是其高端定位的一部分。
解读：按 BN 的价格，一个完整的推荐身体疗程（4 次）约为每部位 $5,600——与多周期 CoolSculpting 方案相当，但附带紧致与橘皮改善。多伦多基准价格不公开；美国诊所也大多将价格放在咨询之后。这意味着加拿大 Onda 的公开价格锚点此刻正由两家 BC 郊区诊所设定——对一个有公信力的医学旗舰而言，这是定价权机会（见第10节）。
最重要的发现是北美自然评价量之少：RealSelf 没有该疗程页面或 "Worth It" 评分，Reddit 上几乎没有讨论帖，提供该疗程的加拿大诊所的 Google 评论中也尚无针对该设备的具体提及。这台设备在北美实在太新了。来自亚洲、欧洲和英国的评价（部分带有推广性质——需谨慎对待）在以下主题上高度一致：
2024 年国际共识论文（Bioengineering）报告：腹围中位数减少 −3.9 cm，大转子部位 −2.8 cm，3 个月时橘皮评分显著改善，6 次治疗后颏下改善，且无不良事件报告——满意度 3.3–4.1/5。另有组织学、颏下松弛、产后松弛等支持性研究。对热机制设备尤为关键的一点：Onda 迄今没有反常性脂肪增生（PAH）病例报告——PAH 正是在某研究系列中发生率高达约 1/138、引发 Linda Evangelista 诉讼并严重损害 CoolSculpting 消费者声誉的并发症。
Onda 文献规模小、随访期短、且部分与厂商相关；没有与 CoolSculpting 或任何竞品的头对头试验，而被广泛引用的 1 年随访研究（Salsi 等，Skin Research and Technology）已被撤稿——切勿引用。"无 PAH 报告"是诚实的说法；"零 PAH 风险"则站不住脚。营销文案应侧重舒适度、零恢复期、三重适应症及共识论文数据，并以医生监督作为信任背书。
三股潮流定义了需求，且方向各不相同：
本地情况：大温地区 CoolSculpting、Emsculpt Neo 和大路货射频（Venus 等）已高度饱和，但橘皮组织疗程覆盖稀薄——在 VLSCC 的西区直接竞争对手中，仅 Arbutus Laser（VelaShape III）和 Project Skin MD（EMTone）拥有橘皮设备；全区域仅两家诊所拥有 Onda，且都不是温哥华市区的医生旗舰定位。消费者对 Onda 品牌的认知几乎为零，这是双刃剑：尚无主动搜索需求（营销负担落在诊所身上），但也没有既定的价格/定位预期需要对抗。
| 市场参与者 | 当前促销活动（2026年8月） |
|---|---|
| BN Skin & Laser | "8.8 六周年庆"活动（$88 起）；"夏日身材计划"；Thermage+Ultherapy 组合促销；"首次体验价"折扣入门疗程；Glow Club 会员 $1,600/年。（Onda 是否包含在 8.8/夏日促销中未确认。） |
| Derma 9 | 七月促销：全脸 Onda 免费能量升级 60→80 kJ；面部套餐 3 次 + 1 次免费（$2,940）；存在"八月特惠"但内容未确认（页面 404）。 |
| The Face Lab（多伦多参照） | 完全不打折。上市机制取而代之：预上市优先候补名单（优先体验、优先咨询、发布会邀请）、咨询制定价、分期付款。高端稀缺打法。 |
规律：现有诊所靠折扣（剂量升级、买3送1、活动价）；高端进入者（Face Lab）拒绝打折，转而出售"优先权"。
成为温哥华市区第一家医生主导的 Onda Pro 诊所——不是把它包装成又一台减脂仪器，而是作为诊所对橘皮组织（VLSCC 自身 40+ 项目菜单及西区大部分竞争对手的空白）以及 GLP-1 后/产后身体修复的专门答案。先发定位仍然可得：没有任何现有诊所占据身体叙事、医学叙事或英语主流市场。
| 因素 | 评估 |
|---|---|
| 竞争空白 | 强。仅 2 家郊区提供者，均以面部为主、均为韩式美容细分；温哥华市区为零；经销商总部就在温哥华市中心（关系筹码——可谈判上市支持、区域独家或"培训中心"地位，如 VLSCC 当年与 Ultherapy 的合作）。 |
| 需求契合度 | 强。品类正转向 Onda "边塑形边紧致"的特性；VLSCC 的 CoolSculpting 业务暴露在同样的 −40% 逆风之下，需要这一对冲。 |
| 经济性 | 有利但未量化。无耗材 → 单次高边际贡献、低成本"首次体验"促销；设备成本未确认（引用约 13–17 万美元，可信度低）。按 BN 每部位 $1,400 和 4 次疗程计算，中等利用率下回本期可能 < 18 个月——需用 Cartessa 真实数字建模。 |
| 风险 | 真实存在。消费者品牌认知为零（VLSCC 必须自己创造它要收割的需求）；证据基础薄弱且有撤稿，约束宣传空间；效果渐进 → 预期管理是第一大差评风险；Health Canada 许可证待核实；与 CoolSculpting 投资的内部渠道冲突。 |
VLSCC 各项目逐一对照 Onda 三大适应症的暴露程度：
| VLSCC 项目 | 与 Onda 的重叠 | 风险与管理 |
|---|---|---|
| CoolSculpting Elite（$800/周期，10 台设备，研究中心地位） | 高——同样的腹部/侧腰/大腿/手臂减脂患者 | 蚕食风险最高、内部阻力也最大（沉没资本、与 Allergan 的关系）。以角色分工管理：CoolSculpting = 皮肤质量好的患者的局部脂肪减容；Onda = 脂肪伴松弛、小范围精修、抗拒冷冻的患者、GLP-1 后"泄气"。这是不同的咨询路径，而非相互竞争的报价。 |
| Emsculpt Neo / CoolTone | 部分（Neo 的射频减脂成分） | 低风险——增肌是独立诉求。且具有互补性："Onda 精修紧致 + Emsculpt 增肌塑形"是文献中已发表的组合（组合研究中腰围 −4.2 cm），也是 VLSCC 天然的套餐。 |
| Thermage（身体）（$1,800 起） | 身体紧致方面中度重叠 | VLSCC 的 Thermage 业务似以面部为主；将 Onda 定位为身体紧致的默认选择（单次更便宜、更舒适），Thermage 保留给面部及偏好单次治疗的患者。 |
| Ultherapy / Sofwave / Sylfirm（面部） | 低——除非 VLSCC 营销 Onda 的面部 "Pocket" 手具 | 刻意不以 Onda 面部应用作为主打。那里是 VLSCC 紧致业务的核心资产（"Ultherapy 第一提供者"），也是现有诊所（BN/Derma 9）选择的主战场。面部 Onda 留作储备。 |
| 橘皮组织 | 无——纯粹空白 | VLSCC 目前 40+ 项目菜单中没有任何橘皮疗程。Onda 吸引的每一位橘皮患者按定义都是增量收入。 |
| Lipodissolve（$575 起） | 低（小部位、下巴） | 保留为经济型/小部位选项；仅在患者抗拒针剂时使用 Onda 下巴方案。 |
整体判断：如果泛泛营销，Onda 约三分之二的适应症会与 VLSCC 现有资产相撞。蚕食问题完全是定位问题——下文的策略正是为解决它而设计的。
不要把 Onda 作为"溶脂机"推出——那会让它与你自己的 CoolSculpting 业务及饱和市场正面相撞。应将其作为诊所的一个新品类推出："身体焕新——抚平、紧致、精修"，锚定菜单上其他项目都做不到的三件事：橘皮抚平、减脂同时紧肤、减重后（GLP-1/产后）身体修复。抢占现有诊所尚未认领的头衔："温哥华首家医生主导的 Onda Pro 诊所"。倚重"30 年历史/医生主导/研究中心"的信任资产——这是 BN 和 Derma 9 都无法复制的差异化，能把一台新设备变成一个安全的选择。
在全诊所固化一套咨询话术：
这套规则完成了战略任务：Onda 从不与 CoolSculpting 争夺同一位患者——它承接的是 CoolSculpting 正在流失的患者（松弛、担心 PAH、GLP-1 人群），并为留下的患者增加第二张订单。
研究中标记为未确认的事项：Health Canada MDALL 许可证状态；全新 Onda Pro 设备成本；Derma 9 $980 身体价格的计价单位；BN "8.8/夏日"促销及 Derma 9 八月特惠的内容；BN/Derma 9 的"官方合作伙伴"说法是否获 Cartessa 认可；VLSCC 的 Emsculpt Neo 价格（未公开）。